JP2025502346A5 - - Google Patents
Info
- Publication number
- JP2025502346A5 JP2025502346A5 JP2024542251A JP2024542251A JP2025502346A5 JP 2025502346 A5 JP2025502346 A5 JP 2025502346A5 JP 2024542251 A JP2024542251 A JP 2024542251A JP 2024542251 A JP2024542251 A JP 2024542251A JP 2025502346 A5 JP2025502346 A5 JP 2025502346A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- vegf
- dcas9
- dna
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/071930 | 2022-01-14 | ||
| CN2022071930 | 2022-01-14 | ||
| PCT/CN2023/071521 WO2023134658A1 (en) | 2022-01-14 | 2023-01-10 | Method of modulating vegf and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502346A JP2025502346A (ja) | 2025-01-24 |
| JP2025502346A5 true JP2025502346A5 (https=) | 2026-01-20 |
Family
ID=87280101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024542251A Pending JP2025502346A (ja) | 2022-01-14 | 2023-01-10 | Ｖｅｇｆを調節する方法およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250066772A1 (https=) |
| EP (1) | EP4463551A1 (https=) |
| JP (1) | JP2025502346A (https=) |
| KR (1) | KR20240133745A (https=) |
| CN (1) | CN118525093A (https=) |
| AU (1) | AU2023207727A1 (https=) |
| CA (1) | CA3247727A1 (https=) |
| TW (1) | TW202342743A (https=) |
| WO (1) | WO2023134658A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025507990A (ja) * | 2022-03-04 | 2025-03-21 | エピジェニック・セラピューティクス・インコーポレイテッド | ゲノム編集の組成物及び方法 |
| WO2025261475A1 (zh) * | 2024-06-21 | 2025-12-26 | 益杰立科(上海)生物科技有限公司 | 靶向血管内皮生长因子的工程化基因转录阻抑工具及用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067317B2 (en) * | 2000-12-07 | 2006-06-27 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
| WO2021243105A1 (en) * | 2020-05-28 | 2021-12-02 | University Of Southern California | Composition and method for treating retinal vascular disease with vegf gene disruption |
| CN111748583A (zh) * | 2020-07-17 | 2020-10-09 | 池嘉栋 | 一种基于CRISPR/dCas9的诱导型DNA甲基化编辑系统 |
-
2023
- 2023-01-10 US US18/724,421 patent/US20250066772A1/en active Pending
- 2023-01-10 CN CN202380016709.8A patent/CN118525093A/zh active Pending
- 2023-01-10 JP JP2024542251A patent/JP2025502346A/ja active Pending
- 2023-01-10 AU AU2023207727A patent/AU2023207727A1/en active Pending
- 2023-01-10 KR KR1020247026893A patent/KR20240133745A/ko active Pending
- 2023-01-10 EP EP23740000.7A patent/EP4463551A1/en active Pending
- 2023-01-10 WO PCT/CN2023/071521 patent/WO2023134658A1/en not_active Ceased
- 2023-01-10 CA CA3247727A patent/CA3247727A1/en active Pending
- 2023-01-13 TW TW112101592A patent/TW202342743A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240309373A1 (en) | SPECIFIC SYNTHETIC CHIMERIC XENONUCLEIC ACID GUIDE RNA; s(XNA-gRNA) FOR ENHANCING CRISPR MEDIATED GENOME EDITING EFFICIENCY | |
| KR20160097331A (ko) | 뉴클레오티드 반복 장애에서의 ｃｒｉｓｐｒ-ｃａｓ 시스템의 조성물 및 방법 및 용도 | |
| JP2025502346A5 (https=) | ||
| WO2023165597A1 (en) | Compositions and methods of genome editing | |
| TW202333747A (zh) | 調節ｐｃｓｋ９之方法及其用途 | |
| WO2021113536A1 (en) | Systems and methods for lipid nanoparticle delivery of gene editing machinery | |
| JP2022533358A5 (https=) | ||
| KR20250124885A (ko) | 복합체 및 이의 용도 | |
| TW202440931A (zh) | 融合物及其用途 | |
| CN118043461A (zh) | 方法 | |
| JP2025507359A (ja) | 増強されたｄｎａデンドリマー及びその使用方法 | |
| JP2020528735A (ja) | 反復伸長変異のためのゲノム編集システム | |
| WO2024255823A1 (zh) | 靶向乙型肝炎病毒基因的表观编辑工具 | |
| CN112888461A (zh) | 抗凝因子的基因编辑 | |
| JP2025506419A5 (https=) | ||
| EP3690046A2 (en) | Composition for treatment of hemophilia, comprising crispr/cas system having coagulation factor viii gene inversion correction potential | |
| US20240391968A1 (en) | Induction of dna strand breaks at chromatin targets | |
| TW202606727A (zh) | 靶向抑制素亞基βＥ（ＩＮＨＢＥ）的工程化基因轉錄阻抑工具及其用途 | |
| WO2025261474A1 (zh) | 靶向抑制素亚基βE(INHBE)的工程化基因转录阻抑工具及其用途 | |
| WO2025261475A1 (zh) | 靶向血管内皮生长因子的工程化基因转录阻抑工具及用途 | |
| HK40120944B (zh) | 基因组编辑的组合物和方法 | |
| WO2025261493A1 (zh) | 通过表观编辑靶向调节pcsk9的方法及其用途 | |
| HK40120944A (zh) | 基因组编辑的组合物和方法 | |
| WO2025167914A1 (zh) | 通过表观编辑多靶点治疗疾病的方法 | |
| WO2026006542A2 (en) | Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome |